Asymptomatic aortic stenosis. When to operate, when to follow?;Asymptomatische aortenstenose. wann soll man operieren? Wann kann man zuwarten?

Herz

Volumn 31, Issue 7, 2006, Pages 664-669

  Baumgartner, Helmut ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Aortic stenosis; Therapeutic concepts; Timing of surgery

Indexed keywords

AORTA VALVE STENOSIS; ARTERY CALCIFICATION; CARDIOVASCULAR RISK; CLINICAL FEATURE; DISEASE COURSE; DISEASE SEVERITY; EXERCISE TEST; HEMODYNAMICS; HUMAN; PREVENTIVE MEDICINE; REVIEW;

AGE FACTORS; AGED; AORTIC VALVE STENOSIS; CALCINOSIS; CLINICAL TRIALS; DEATH, SUDDEN, CARDIAC; DISEASE PROGRESSION; ECHOCARDIOGRAPHY; EXERCISE; EXERCISE TEST; FOLLOW-UP STUDIES; HUMANS; NATRIURETIC PEPTIDE, BRAIN; PATIENT SELECTION; PROGNOSIS; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS;

EID: 33750535427     PISSN: 03409937     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00059-006-2871-1     Document Type: Review

References (16)

1. Amato MC, Moffa PJ, Werner KE, et al. Treatment decision in asymptomatic aortic valve stenosis: role of exercise testing. Heart 2001;86:381-6.
2. Bergler-Klein J, Klaar U, Herger M, et al. Natriuretic peptides predict symptom-free survival and postoperative outcome in severe aortic stenosis. Circulation 2004;109:2302-8.
3. Bonow RO, Carabello B, de Leon AC, et al. ACC/AHA guidelines for the management of patients with valvular heart disease. A report of the American College of Cardiology/ American Heart Association. Task Force on Practice Guidelines (Committee on Management of Patients with Valvular Heart Disease). J Am Coll Cardiol 1998;32:1486-588.
4. Das P, Rimington H, McGrane H, et al. Exercise testing to stratify risk in aortic stenosis. Eur Heart J 2005;26:1309-13.
5. Iung B, Gohlke-Barwolf, Tornos P, et al., on behalf of the Working Group on Valvular Heart Disease. Recommendations on the management of the asymptomatic patient with valvular heart disease. Eur Heart J 2002;23:1253-66.
6. Lim P, Monin JL, Monchi M, et al. Predictors of outcome in patients with severe aortic stenosis and normal left ventricular function: role of B-type natriuretic peptide. Eur Heart J 2004;25:2048-53.
7. Lund O, Nielsen TT, Emmertsen K, et al. Mortality and worsening of prognostic profile during waiting time for valve replacement in aortic stenosis. Thorac Cardiovasc Surg 1996;44:289-95.
8. Mohler ER. Mechanisms of aortic valve calcification. Am J Cardiol 2004;94:1396-402.
9. Otto CM. Timing of aortic valve surgery. Heart 2000;84:211-8.
10. Otto CM, Burwash IG, Legget ME, et al. Prospective study of asymptomatic valvular aortic stenosis. Clinical, echocardiographic, and exercise predictors of outcome. Circulation 1997;95:2262-70.
11. Pellikka PA, Nishimura RA, Bailey KR, et al. The natural history of adults with asymptomatic, hemodynamically significant aortic stenosis. J Am Coll Cardiol 1990;15:1012-7.
12. Pellikka PA, Sarano ME, Nishimura RA, et al. Outcome of 622 adults with asymptomatic, hemodynamically significant aortic stenosis during prolonged follow-up. Circulation 2005;111:3290-5.
13. Rosenhek R, Binder T, Porenta G, et al. Predictors of outcome in severe, asymptomatic aortic stenosis. N Engl J Med 2000;343:611-7.
14. Rosenhek R, Maurer G, Baumgartner H. Should early elective surgery be performed in patients with severe but asymptomatic aortic stenosis? Eur Heart J 2002;23:1417-21.
15. Stewart BF, Siscovick D, Lind BK, et al. Clinical factors associated with calcific aortic valve disease. Cardiovascular Health Study. J Am Coll Cardiol 1997;29:630-4.
16. STS National Database. STS U.S. cardiac surgery database: 1997 aortic valve replacement patients: preoperative risk variables. Chicago: Society of Thoracic Surgeons, 2000 (http:/www.ctsnet.org/doc/3031).